We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting. For more information about the use of cookies or our use of data, see our Cookies notice or Privacy notice

Cookies settings I agree I disagree

Cookies information

Our site uses tools, such as cookies, to analyze and improve your experience. You can unsubscribe below:

Statistic

We use tools such as Google Analytics to track web traffic and check the effectiveness of our site.

Necessary

Cookies required for essential services and features such as login forms, shopping cart integration and access control. Without them, our website cannot function properly and we cannot provide any services. Deactivation is not available.

These settings will be kept for 24h

Events

ESOTA 2023

ESOTA 2023
Check the link
Events
ESOTA 2023

Bioxodes presented at the 12th ESOTA educational seminar that focused on: “Running international trials: different perspectives”.

Charlotte CorbisierA

  • A
    Bioxodes SA, Gosselies, Belgium
Our Clinical Project Manager, Charlotte Corbisier, gave a talk about the initiation of the phase IIa study with our first-in-class drug candidate, Ir-CPI, designed to prevent thrombosis and neuroinflammation in haemorrhagic stroke patients.